XARELTO®: Dosing in the treatment and reduction in the risk of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE)
DOSING FOR DVT/PE TREATMENT AND RISK REDUCTION
15 mg
For the first 21 days, twice daily with food, at the same time each day in patients with a CrCl ≥30 mL/min
20 mg
Starting at day 22, once daily with food, at the same time each day for remaining treatment in patients with a CrCl ≥30 mL/min
15 mg
For the first 21 days, twice daily with food, at the same time each day in patients with a CrCl ≥30 mL/min
20 mg
Starting at day 22, once daily with food, at the same time each day for remaining treatment in patients with a CrCl ≥30 mL/min
10 mg
Once daily with or without food after ≥6 months of standard anticoagulant treatment in patients with a CrCl ≥30 mL/min
Renal Dose Consideration
- Avoid using XARELTO® in patients with CrCl <30 mL/min
A CONVENIENT 30-DAY STARTER PACK FOR PATIENTS WITH DVT/PE
*The decision regarding initiation setting should be based on the prescriber's clinical judgment.
CrCl = creatinine clearance.